Pfizer
Jarjieh Fang, MPH, is a seasoned public health professional currently serving as a Senior Research Associate in Implementation Science at Evidera since May 2022 and at Thermo Fisher Scientific since December 2022. With a strong focus on evidence generation for payer and regulatory audiences, Jarjieh leads study design and execution, manages interdisciplinary teams, and facilitates data analysis in multi-country Phase III/IV trials. Founding the initiative COVID Can I Do It, Jarjieh supported individuals in understanding COVID-19 risks. Prior experience includes positions at ICAP at Columbia University and Pharmerit International, where involvement encompassed qualitative research, patient-centered outcomes, and real-world evidence analysis. Jarjieh holds a Master’s in Public Health from The George Washington University and a Bachelor’s in Neurobiology and Political Science from the University of Wisconsin-Madison.
This person is not in the org chart
This person is not in any teams
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.